A Phase I/II Clinical Trial of Pomalidomide With Melphalan and Dexamethasone in Patients With Newly Diagnosed Untreated Systemic AL Amyloidosis: Trial Stopped During Phase I
Phase of Trial: Phase I/II
Latest Information Update: 25 May 2016
At a glance
- Drugs Pomalidomide (Primary) ; Dexamethasone; Melphalan
- Indications Amyloidosis
- Focus Adverse reactions
- 18 Feb 2016 Status changed from active, no longer recruiting to discontinued, according to ClinicalTrials.gov record.
- 15 Sep 2015 Status changed from discontinued to active, no longer recruiting as reported by ClinicalTrials.gov.
- 14 Aug 2015 According to the ClinicalTrials.gov record, status changed from active, no longer recruiting to discontinued.